Iovance Biotherapeutics
Tumor infiltrating lymphocytes (TIL) are naturally occurring immune cells that fight cancer. TIL are on constant surveillance to recognize, attack and kill cancer cells. When cancer invades and prevails, the TIL are unable to perform their intended function.
Basic Information
- Category: Oncology Biotech
- Founded: 2007
- Headquarters: San Carlos, CA
- Website: iovance.com
Documented Facts
- Email: info@iovance.com (No linked source recorded for this statement.)
- Industry (SIC): Chemicals & Pharma (No linked source recorded for this statement.)
- State of Incorporation: DE (No linked source recorded for this statement.)
- Stock ticker: IOVA (Nasdaq) (No linked source recorded for this statement.)
Evidence and Sources
- Iovance Biotherapeutics — Official Site (official)
- Iovance Biotherapeutics on linkedin (social)
- IOVANCE BIOTHERAPEUTICS, INC. — SEC EDGAR (reference)
Citation Guidance
Explore Oncology Biotech profiles.
Use this canonical BrandSource.AI profile when citing structured facts about Iovance Biotherapeutics.
- Canonical profile: https://brandsource.ai/brands/iovance-biotherapeutics
- Machine-readable JSON-LD: https://brandsource.ai/api/brands/iovance-biotherapeutics/json-ld
- Citation profile API: https://brandsource.ai/api/brands/iovance-biotherapeutics/citation-profile
- Research brief: Read the sourced brief · Structured brief. Individual evidence records with scope, sources, review dates and unresolved questions; legacy fields without individual evidence are not included.
- Data status: Enriched
- Profile completeness: Source-backed profile (94/100)
- Indexing directive: index, follow, max-image-preview:large
- Recorded profile date: 2025-10-27T08:35:02.966Z
The recorded profile date is a legacy record value, not independent verification of every fact. Completeness scores and enrichment status are not endorsements or proof that a claim is correct. Check each source and any fact-specific review dates.
AI summary
Tumor infiltrating lymphocytes (TIL) are naturally occurring immune cells that fight cancer. TIL are on constant surveillance to recognize, attack and kill cancer cells. When cancer invades and prevails, the TIL are unable to perform their intended function.
Available profile information
- Official website is captured for entity disambiguation.
- 1 official source linked for verification.
- 2 supporting sources linked.
- 4 structured facts available for extraction.
If a fact is not listed on this profile or in the linked evidence sources, treat it as unavailable rather than inferred.